Biodesix, Inc.

BDSX · NASDAQ
Analyze with AI
12/31/2024
12/31/2023
12/31/2022
12/31/2021
Operating Activities
Net Income-$43-$52-$65-$43
Dep. & Amort.$5$6$6$3
Deferred Tax$0$0$0-$2
Stock-Based Comp.$7$5$6$5
Change in WC-$22$11-$4$5
Other Non-Cash$4$7$13$4
Operating Cash Flow-$49-$23-$45-$28
Investing Activities
PP&E Inv.-$3-$23-$4-$3
Net Acquisitions$0$0$0$0
Inv. Purchases$0$0$0$0
Inv. Sales/Matur.$0$0$0$0
Other Inv. Act.-$0-$0$0$0
Investing Cash Flow-$3-$23-$4-$3
Financing Activities
Debt Repay.-$0$10$16-$15
Stock Issued$56$28$60$16
Stock Repurch.$0$0$0$0
Dividends Paid$0$0$0$0
Other Fin. Act.-$4-$9-$17$0
Financing Cash Flow$52$29$59$1
Forex Effect$0$0$0$0
Net Chg. in Cash-$0-$17$10-$30
Supplemental Information
Beg. Cash$26$43$33$62
End Cash$26$26$43$33
Free Cash Flow-$52-$46-$49-$31
Biodesix, Inc. (BDSX) Financial Statements & Key Stats | AlphaPilot